Navigation Links
DecisionQ Partners With Thomas Jefferson University to Reveal Insights for Cancer Therapy
Date:4/29/2009

Partnership integral piece of consortium recently awarded five-year, $6.7 million Susan G. Komen for the Cure Promise Grant

WASHINGTON, April 29 /PRNewswire/ -- Thomas Jefferson University's Kimmel Cancer Center has partnered with DecisionQ, a leader in predictive analytics and machine learning to uncover life-saving answers hidden in the center's proprietary and extensive cancer registries. DecisionQ will leverage its expertise in developing predictive algorithms to identify how patients will respond to different therapeutic options for breast and colon cancers.

The team is part of a consortium that was recently awarded a Susan G. Komen for the Cure Promise Grant of nearly $6.7 million for five years of continued breast cancer research. Promise grants support multi-disciplinary research with the greatest potential to significantly reduce breast cancer incidence and/or mortality within the next decade.

"Identification of therapy-relevant biomarkers is a crucial part of breast cancer research, as there are many different biomarkers that could predict treatment response and outcome, and serve as targets for treatment," said Hallgeir Rui, M.D., Ph.D., professor of Cancer Biology at Thomas Jefferson University. "DecisionQ's Faster AnalyticsTM will be used to further refine the team's predictive models in breast cancer, helping us to identify protein biomarker patterns that can be used to make sure patients are offered the most appropriate therapy."

Leading experts in the fields of decision analysis, statistics and machine learning have developed the technology and approach that DecisionQ applies in creating MMIA's (multi marker interpretive assays), greatly enhancing the quality of human judgment in an interactive, real-time environment at a low marginal cost.

"More than a million new cancer diagnoses are documented each year, giving researchers vast amounts of data with which to work," said Todd Radano, co-founder of DecisionQ. "Applying advances in analytics via machine learning will assist scientists in taking what is known about the disease and developing actionable insights that could ultimately save lives."

About DecisionQ Corporation

DecisionQ is a leader in predictive analytics and machine learning technologies with expertise in the healthcare, life sciences, financial services and security industries. Through the application of its advanced technologies and methods it delivers customers substantial improvements in the speed and quality of decision making by allowing them to quickly turn data into actionable insights. To learn more about DecisionQ visit www.decisionq.com.

                                         Contact:
                                         Laura Phillips, Vehr Communications
                                         513.381.8347
                                         lphillips@vehrcommunications.com


'/>"/>
SOURCE DecisionQ Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. E&K Scientific Announces Partnership with Sciformatix
2. PRA International Presents Key Budgeting Strategies at 18th Annual CRO Partnerships Conference
3. Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting
4. Brazils top automakers to distribute 2 million copies of the Ethanol Handbook in partnership with the Brazilian Sugarcane Industry Association
5. Childrens Memorial Research Center, Chicago Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
6. ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
7. US Oncology Clinical Development Attends Partnerships With CROs
8. Aviation partners to cut 500,000 tonnes of CO2 a year
9. ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions
10. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
11. Van Andel Institute Joins the MetaMiner Oncology Partnership Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2019)... ... February 14, 2019 , ... ... based leak testing systems for the pharmaceutical, biotechnology and food industries, formally announced ... forward. Brian Mulhall has been named Chief Executive Officer and will ...
(Date:2/2/2019)... ... January 31, 2019 , ... Dust off your Doc ... it hosts the Nuriv 2019 Expo West Music and Tech Festival at the ESports ... foster innovation in the natural foods, beverages, and dietary supplement industries, the Nuriv Music ...
(Date:1/30/2019)... ... January 29, 2019 , ... MabPlex International Ltd ... the global biopharmaceutical and biotechnology industries with sites in China and the United ... global investors lead by China's State Development & Investment Corporation (SDIC) and Shenzhen ...
(Date:1/30/2019)... ... January 29, 2019 , ... Could a computer detect a ... tricky math problem on an online tutoring program? Could it detect deep reflection ... science assistant professor Erin Solovey is working to develop a system ...
Breaking Biology Technology:
(Date:2/2/2019)... , ... January 31, 2019 , ... ... microbial genomics, has awarded microbiome research support in study design, planning, sample collection, ... HCLD, Professor of Obstetrics and Gynecology, and Dr. Sara Vaughn, MD, Reproductive Endocrinology ...
(Date:2/2/2019)... ... February 01, 2019 , ... ... Clinical Testing Laboratories by A2LA, which establishes requirements for medical laboratories to demonstrate ... laboratory is already CLIA-licensed as well as College of American Pathologists (CAP)-accredited, a ...
(Date:1/25/2019)... (PRWEB) , ... January 24, 2019 , ... ... Dr. Julia Oh, PhD, Assistant Professor of Microbiology at the Jackson Laboratory (JAX), ... from around the world, Dr. Oh will bring to uBiome expertise in skin ...
Breaking Biology News(10 mins):